Prognosis of Tyrosine Kinase Inhibitor Therapy for Non-Small Cell Lung Cancer

Introduction: Non-small cell lung cancer (NSCLC) was the primary cause of death in lung cancer. Tyrosine kinase inhibitors (TKIs) were one of the management options for NSCLC. Meanwhile, serum carcinoembryonic antigen (CEA) plays a crucial role in the diagnosis and prognosis of NSCLC patients. This...

Full description

Bibliographic Details

Published in:	Jurnal Respirasi
Main Authors:	Agus Andreas Santoso, Suryanti Dwi Pratiwi, Yani Jane Sugiri, Harun Al Rasyid, Aditya Sri Listyoko
Format:	Article
Language:	English
Published:	Universitas Airlangga 2025-05-01
Subjects:	carcinoembryonic antigen (cea) egfr-tki nsclc overall survival (os) progression-free survival (pfs)
Online Access:	https://e-journal.unair.ac.id/JR/article/view/68755